The TBO1 monoclonal antibody specifically binds to human CD57, a 110 kDA glycoprotein expressed on a subset of natural killer lymphocytes, cells, neural cells and striated muscle.
It is reported that the molecule is involved in cell-matrix interactions and is upregulated in some disease states.
